Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Atreaon Inc.
DescriptionTumor necrosis factor (TNF) alpha and tumor necrosis factor alpha receptor antagonist
Molecular Target Tumor necrosis factor (TNF) receptor 2 (TNFR2) ; Tumor necrosis factor (TNF) receptor 1 (TNFRSF1A) (TNFR1) (CD120a)
Mechanism of ActionTumor necrosis factor receptor (TNFR) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today